{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(8)"],"submitter":["Cruz-Monteagudo M"],"pubmed_abstract":["Background
In the context of the current drug discovery efforts to find disease modifying therapies for Parkinson's disease (PD) the current single target strategy has proved inefficient. Consequently, the search for multi-potent agents is attracting more and more attention due to the multiple pathogenetic factors implicated in PD. Multiple evidences points to the dual inhibition of the monoamine oxidase B (MAO-B), as well as adenosine A2A receptor (A2AAR) blockade, as a promising approach to prevent the neurodegeneration involved in PD. Currently, only two chemical scaffolds has been proposed as potential dual MAO-B inhibitors/A2AAR antagonists (caffeine derivatives and benzothiazinones).Methods
In this study, we conduct a series of chemoinformatics analysis in order to ev"],"journal":["Current neuropharmacology"],"pagination":["1117-1135"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5725544"],"repository":["biostudies-literature"],"pubmed_title":["Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold."],"pmcid":["PMC5725544"],"pubmed_authors":["Perera-Sardina Y","Borges F","Perez-Castillo Y","Cruz-Monteagudo M","Sanchez-Rodriguez A","Cordeiro MNDS","Helguera AM","Paz-Y-Mino C","Tejera E"],"additional_accession":[]},"is_claimable":false,"name":"Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.","description":"Background
In the context of the current drug discovery efforts to find disease modifying therapies for Parkinson's disease (PD) the current single target strategy has proved inefficient. Consequently, the search for multi-potent agents is attracting more and more attention due to the multiple pathogenetic factors implicated in PD. Multiple evidences points to the dual inhibition of the monoamine oxidase B (MAO-B), as well as adenosine A2A receptor (A2AAR) blockade, as a promising approach to prevent the neurodegeneration involved in PD. Currently, only two chemical scaffolds has been proposed as potential dual MAO-B inhibitors/A2AAR antagonists (caffeine derivatives and benzothiazinones).Methods
In this study, we conduct a series of chemoinformatics analysis in order to ev","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Nov","modification":"2026-04-16T05:10:48.884Z","creation":"2019-03-26T23:35:56Z"},"accession":"S-EPMC5725544","cross_references":{"pubmed":["28093976"],"doi":["10.2174/1570159X15666170116145316"]}}